The synergy of TPL and selinexor in MLL-R acute myeloid leukemia via Rap1/Raf/MEK pathway-mediated MYC downregulation

MLL gene rearrangement recurrently occurs in acute myeloid leukemia (MLL-r AML), which is closely associated with chemotherapy insensitivity and unfavorable clinical outcomes. More importantly, there are limited therapeutic options for the management of patients with MLL-r AML, thus necessitating no...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Manman Deng, Peicui Huang, Lijuan Wang, Yuelong Jiang, Zhenling Guo, Hongpeng Duan, Jie Zha, Haijun Zhao, Guowei Li, Bing Xu
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Elsevier 2025-07-01
Reeks:	Translational Oncology
Onderwerpen:	MLL rearrangement (MLL-r) Acute myeloid leukemia (AML) Triptolide XPO1 inhibitor selinexor Synergy MYC
Online toegang:	http://www.sciencedirect.com/science/article/pii/S1936523325001305
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!